Market Place
Sourcing Support
From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
09 Oct 2019 //
PHARMACEUTICAL TECHNOLOGY
Eli Lilly picks up an oral GLP-1 diabetes drug from Roche sub for $50M
27 Sep 2018 //
ENDPTS
ADA: Trulicity bests Victoza, Bydureon in real-world study
25 Jun 2018 //
FIERCE PHARMA
AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval
03 Apr 2018 //
DRUGDELIVERY
Novo gets FDA blessing for Type 2 diabetes drug Ozempic
06 Dec 2017 //
FIERCE PHARMA
AZ GLP-1 trailer Bydureon gets a facelift with BCise approval
23 Oct 2017 //
FIERCE PHARMA
AstraZeneca receives US FDA approval for once-weekly Bydureon BCise injectable
23 Oct 2017 //
PHARMABIZ
Why did AstraZeneca`s Bydureon fail to cut CV risks?
14 Sep 2017 //
FIERCE PHARMA
AstraZeneca puts Brilinta, Bydureon on pay-for-performance bandwagon
31 May 2017 //
FIERCE PHARMA
AstraZeneca asthma shot hits goal but diabetes drug lags rival
23 May 2017 //
REUTERS
AZ Taps 3SBio to Help Drive Sales of Diabetes Meds Byetta, Bydureon in China
14 Oct 2016 //
FIERCE PHARMA
AstraZeneca, Teva settle Byetta patent suit; generics on their way
25 Jun 2016 //
FIERCE PHARMA
Novo Nordisk`s weekly diabetes drug goes 5-for-5 in Phase III
24 Feb 2016 //
FIERCE BIOTECH
Once-a-week diabetes meds are similar in safety and effectiveness
07 Dec 2015 //
REUTERS
AZ`s Bydureon tops doc-payments list with $22B
08 Jul 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.